TrialPLoS medicine2021

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.

Neil Formica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.